MAFLD Criteria May Overlook a Subtype of Patient with Steatohepatitis and Significant Fibrosis.

Diabetes Metab Syndr Obes · 2021 · PMC8326380 · PMID 34349535

Europe PMC DOI

hedged sentence

0.0570

closest p · 1.1× alpha

0.0570

boldest claim

The sentences

did not reach statistical significanceP = 0.057so close (0.05 < p ≤ 0.1)

The proportion of moderate to severe steatosis was 50.70% in the MAFLD group and 44.44% in the NAFLD group, but the difference did not reach statistical significance (P = 0.057).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.